<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Zarifyan, Alla</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Udell, Jacob A.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Extended DAPT Reduces Secondary Cardiovascular Events in Patients With Prior MI</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2015-10-21 10:14:30</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">17-19</style></pages><abstract><style  face="normal" font="default" size="100%">A meta-analysis of 6 randomized trials demonstrated that when compared with aspirin therapy alone, dual antiplatelet therapy beyond 1 year decreased the risk of major adverse cardiovascular events, myocardial infarction, stroke, and cardiovascular death among high-risk patients with previous myocardial infarction while increasing the risk of major bleeding.</style></abstract><number><style face="normal" font="default" size="100%">28</style></number><volume><style face="normal" font="default" size="100%">15</style></volume></record></records></xml>